Research output per year
Research output per year
Search results
-
2023
Erratum: Addendum: Successful administration of sequential TVEC and pembrolizumab followed by Temozolomide in immunotherapy refractory intracranial metastatic melanoma with acquired B2M mutation (Oncotarget)
Khaddour, K., Dowling, J., Huang, J., Council, M., Chen, D., Cornelius, L., Johanns, T., Dahiya, S. & Ansstas, G., Feb 11 2023, In: Oncotarget. 14, p. 126 1 p.Research output: Contribution to journal › Comment/debate
Open Access -
2021
Erratum: Correction: Aberrant ATRX protein expression is associated with poor overall survival in NF1-MPNST (Oncotarget (2018) 9 33 (23018-23028))
Lu, H. C., Eulo, V., Apicelli, A. J., Pekmezci, M., Tao, Y., Luo, J., Hirbe, A. C. & Dahiya, S., Nov 23 2021, In: Oncotarget. 12, 24, p. 2435-2436 2 p.Research output: Contribution to journal › Comment/debate
Open Access -
2018
An 8-Year-Old Girl with A Supratentorial Mass
Schwetye, K. E., Gauvain, K., Rodriguez, D., Cottrell, C., Limbrick, D. D., Schmidt, R. E. & Dahiya, S., Jan 2018, In: Brain Pathology. 28, 1, p. 125-126 2 p.Research output: Contribution to journal › Comment/debate
Open Access -
BRAF-targeted therapy in the treatment of BRAF-mutant high-grade gliomas in adults
Johanns, T. M., Ansstas, G. & Dahiya, S., Apr 1 2018, In: JNCCN Journal of the National Comprehensive Cancer Network. 16, 4, p. 451-454 4 p.Research output: Contribution to journal › Comment/debate
Open Access8 Scopus citations -
2011
Comment
Chicoine, M. R. & Dahiya, S., Oct 2011, In: Neurosurgery. 69, 4, p. E1015-E1016Research output: Contribution to journal › Comment/debate
1 Scopus citations